Michael Masterson

Co-Founder & Managing Partner at Supermoon Capital

📍 San Francisco Bay Area, United States🔄 Updated July 2026💼 23 investments📅 6 years investing🗓 Last invested Jun 2026
VC🌍 United States20+ investmentsInvested this quarter
23
Total investments
6
Early stage
6
Mid stage
3
Late stage
6y
Years active

Portfolio

21 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor, Board Observer
Jun 2026
Applied Cognition is a clinical stage platform therapeutic company that is first to advance the biology of brain glymphatic function to medical care. Enhancing glymphatic function is a novel approach to preventing progression of neurodegenerative disorders, demonstrated in animal models in several recent papers in leading scientific journals. The Company is the first to develop the ability to continuously measure the function of this important system in humans and to enhance its function using its patent-pending drug asset.
Investor
Feb 2026
Ritual Brands Group acquires and operates founder-built consumer brands for the long term. We focus on strong products, honest brands, and operational execution that compounds over time. No shortcuts. No hype. Just disciplined building.
Investor
Jan 2026
At Lume, we’re building tools to help people understand their health in a way they never could before. We start with the body’s master clock: the circadian rhythm. By measuring hormones like cortisol and melatonin in real time, we make the invisible visible. We’ve helped people around the world uncover a root cause of their fatigue, and finally get their energy back after burnout.
Investor
Dec 2025
Kimba’s technology uses AI to analyze biometric data and offer a personalized scent therapy to improve sleep and health.
Investor
Nov 2025
Athvance Capital is a European investment platform fully dedicated to unlocking long-term value across the global sports industry. The firm invests in emerging and under-commercialised sports IP, and in the technology and service providers that support the industry’s long-term growth.   Combining patient, flexible capital with deep operational expertise, Athvance identifies, integrates, and scales assets at the intersection of sport, media and technology. The firm partners closely with founders and rights-holders to build an operator-led ecosystem that accelerates value creation, fosters innovation and generates sustainable, positive impact. Backed by experienced entrepreneurs, industry experts and long-term investors, Athvance Capital aims to be the partner of choice for building the next generation of sports assets with global reach.
Investor
Sep 2024
Loftie is a wellness company committed to creating stylish, innovative products that help people rest, relax, and recharge. We focus on supporting healthy sleep because it is one of the most critical elements for physical, mental, and emotional wellbeing, yet also one of the most undervalued. We take a mindful approach to technology, using it to inspire refreshing action rather than endless distraction, and we take a thoughtful approach to design, because any object you bring into your life should be as beautiful as it is beneficial. Our products have won numerous awards including Real Simple’s 2022 and 2021 Sleep Awards; Women’s Health Healthy Sleep Awards 2021; Fast Company’s Home Innovation Awards.
late stageDesign
Investor
Jul 2024
Cuddle’s Sleep+ Formula™ brings together 11 science-backed natural ingredients, working in harmony with your body’s rhythms to help you relax, restore, replenish and rebalance. The world is waking up to the need for quality sleep. The transformative kind. Sleep that brings you a feeling of deep rest and rejuvenation. Restores your body and mind. And repairs your cells – inside and out. Sleep is a potent natural elixir that can often feel out of reach. We created Cuddle to put restful nightly sleep in your hands, tonight and every night, so you can experience remarkable sleep health for the long term, with science by your side.
Investor, Board Observer
Apr 2023
Mosanna Therapeutics is a clinical-stage biotech company pioneering a novel pharmaceutical approach to treating obstructive sleep apnea (OSA) with an easily administered nasal spray. Designed to help restore the body’s natural airway control during sleep, Mosanna’s lead therapy, MOS118, offers a drug-based alternative to traditional mechanical treatments and is currently being evaluated in a Phase 1 clinical trial. Founded in 2022, the company has raised more than $80 million from investors including Pivotal bioVenture Partners, EQT Life Sciences, Forbion, Norwest, Broadview Ventures, Forty51 Ventures, Supermoon Capital and High-Tech Gründerfonds (HTGF). Mosanna has offices in Redwood City, California and Basel, Switzerland.
Investor
Feb 2023
Build and deliver exceptional healthcare experiences within apps through passively collected and analysed physical and mental health data. Sahha’s API turns raw device data from wearables and smartphones into powerful insights about user behavioral, physical and mental health. Build next generation healthcare experiences, partner with Sahha.
Investor
Jan 2023
We are building solutions for the millions of people with untreated obstructive sleep apnea.
Investor
Jun 2022
Revery is currently in beta stealth.
Investor
Jun 2022
Helping shift workers sleep better, feel better, and be safer on the job.
Investor
Apr 2022
Moshi is perfect for settling little monsters at bedtime, nap-time, or when big feelings threaten to bubble over. The meditations help kids reset, focus, gain self control & confidence, take proactive vs reactive approaches, & learn SEL skills like social awareness, self-management, & responsible decision-making. 🔬 Scientifically proven to help kids fall asleep 28 mins faster, for 22 mins longer, with 50% fewer night wake-ups 📊 97% of parents say Moshi helps get their kids to sleep more quickly, 95% said using the app makes bedtimes less stressful 💫 Hundreds of original audio stories set in the enchanting world of Moshi ✨ Soothing melodies, soundscapes, ambient noise, calming music, meditations, & more. 🥇 60,000+ 5-star reviews 🏆 2021 NAPPA Winner: Best App 📲 On Google Play & iOs. Free 7-day trial, then $12.99/month or $79.99/year 🔬 📱 Follow @MoshiSleep on IG, Twitter, Tik Tok, Facebook 🤝 Join our community group for parents: https://www.facebook.com/groups/generationmoshi In a recent study of 30 children over 10 days, scientists at New York University discovered that on average, when using Moshi: ○ Kids fell asleep 28 minutes earlier ○ Kids slept for 22 minutes longer ○ Night wakings decreased by up to 50% Includes special guest Stories narrated by legends of stage and screen, including Goldie Hawn and Patrick Stewart.
Investor, Board Observer
Oct 2021
Invicta Medical is a medical technology company that specializes in innovative therapies for sleep apnea.
Investor
Oct 2021
Arctop is a pioneer in the neurotechnology industry. Arctop’s software analyzes brain signals from consumer headwear – such as a hat or headband – and produces an accurate measure of the mind in real-time. The technology can perform high-fidelity decoding of emotion, attention and memory processes – “reading the brain” – outside of laboratory settings, paving the way for integration with personal entertainment and education systems, voice assistants, telemedicine networks, IoT devices, mobile apps and more. Arctop’s first product, Neuos Eureka, is an on-demand brain decoding software platform that provides research-grade audience insights to producers of video and gaming content. Clients include some of the largest global brands and studios, and range from digital content creators and app developers to entertainment and media executives. Future Neuos releases include real-time APIs that provide enterprise, medical and consumer applications with objective measures of brain activity programmatically.
Show all 21 investments ↓
Experience · 28 entries
All (28)
Investments (23)
Founder (3)
Board (7)
2026
Investor, Board Observer
Jun 2026
Applied Cognition is a clinical stage platform therapeutic company that is first to advance the biology of brain glymphatic function to medical care. Enhancing glymphatic function is a novel approach to preventing progression of neurodegenerative disorders, demonstrated in animal models in several recent papers in leading scientific journals. The Company is the first to develop the ability to continuously measure the function of this important system in humans and to enhance its function using its patent-pending drug asset.
Investor
Feb 2026
Ritual Brands Group acquires and operates founder-built consumer brands for the long term. We focus on strong products, honest brands, and operational execution that compounds over time. No shortcuts. No hype. Just disciplined building.
Investor, Board Observer
Feb 2026
We make it easy to access effective mental health care anywhere, anytime. Designed by leading clinical experts, Big Health’s comprehensive mental health solution and app-based treatments expand access to gold standard mental health care. Our offerings are clinically proven to deliver great outcomes, backed by industry-leading research and randomized controlled trials. Our model simplifies access for employers, payers, and patients, which allows us to create an inclusive, scalable, and affordable mental health ecosystem for all. Please note that Big Health will never contact job candidates via text message or any other messaging platform including Telegram. All official correspondence will occur through email. If you have concerns please reach out to careers@bighealth.com.
Investor
Jan 2026
At Lume, we’re building tools to help people understand their health in a way they never could before. We start with the body’s master clock: the circadian rhythm. By measuring hormones like cortisol and melatonin in real time, we make the invisible visible. We’ve helped people around the world uncover a root cause of their fatigue, and finally get their energy back after burnout.
2025
Investor
Dec 2025
Kimba’s technology uses AI to analyze biometric data and offer a personalized scent therapy to improve sleep and health.
Show all 28 entries ↓
Investment activity
2020–2026 · 23 investments
20205202132022420233202422025220264
Recent (last 2 years)Earlier